Ion Beam Applications SA (IBAB) - Total Assets
Based on the latest financial reports, Ion Beam Applications SA (IBAB) holds total assets worth €626.99 Million EUR (≈ $733.02 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Ion Beam Applications SA net assets for net asset value and shareholders' equity analysis.
Ion Beam Applications SA - Total Assets Trend (2000–2024)
This chart illustrates how Ion Beam Applications SA's total assets have evolved over time, based on quarterly financial data.
Ion Beam Applications SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Ion Beam Applications SA's total assets of €626.99 Million consist of 72.7% current assets and 27.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 11.7% |
| Accounts Receivable | €218.10 Million | 35.4% |
| Inventory | €152.80 Million | 24.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €13.99 Million | 2.3% |
| Goodwill | €11.68 Million | 1.9% |
Asset Composition Trend (2000–2024)
This chart illustrates how Ion Beam Applications SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Ion Beam Applications SA (IBAB) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ion Beam Applications SA's current assets represent 72.7% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 11.7% of total assets in 2024, up from 2.4% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 60.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 35.4% of total assets.
Ion Beam Applications SA Competitors by Total Assets
Key competitors of Ion Beam Applications SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$127.41 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Respiri Ltd
AU:RSH
|
Australia | AU$7.08 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
Ion Beam Applications SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.94 | 0.96 | 1.28 |
| Quick Ratio | 0.62 | 0.64 | 0.84 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-30.30 Million | €-17.92 Million | €74.12 Million |
Ion Beam Applications SA - Advanced Valuation Insights
This section examines the relationship between Ion Beam Applications SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.73 |
| Latest Market Cap to Assets Ratio | 0.74 |
| Asset Growth Rate (YoY) | 3.1% |
| Total Assets | €616.10 Million |
| Market Capitalization | $458.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ion Beam Applications SA's assets below their book value (0.74x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Ion Beam Applications SA's assets grew by 3.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Ion Beam Applications SA (2000–2024)
The table below shows the annual total assets of Ion Beam Applications SA from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €616.10 Million ≈ $720.29 Million |
+3.11% |
| 2023-12-31 | €597.53 Million ≈ $698.57 Million |
-4.23% |
| 2022-12-31 | €623.90 Million ≈ $729.40 Million |
+14.26% |
| 2021-12-31 | €546.05 Million ≈ $638.39 Million |
+6.86% |
| 2020-12-31 | €511.00 Million ≈ $597.41 Million |
+20.20% |
| 2019-12-31 | €425.11 Million ≈ $497.00 Million |
+4.39% |
| 2018-12-31 | €407.24 Million ≈ $476.11 Million |
+22.47% |
| 2017-12-31 | €332.52 Million ≈ $388.75 Million |
-12.64% |
| 2016-12-31 | €380.62 Million ≈ $444.98 Million |
-3.73% |
| 2015-12-31 | €395.35 Million ≈ $462.21 Million |
+28.76% |
| 2014-12-31 | €307.06 Million ≈ $358.98 Million |
+8.98% |
| 2013-12-31 | €281.75 Million ≈ $329.40 Million |
-27.04% |
| 2012-12-31 | €386.20 Million ≈ $451.51 Million |
-22.45% |
| 2011-12-31 | €498.01 Million ≈ $582.23 Million |
-5.72% |
| 2010-12-31 | €528.21 Million ≈ $617.53 Million |
+10.13% |
| 2009-12-31 | €479.64 Million ≈ $560.75 Million |
-5.86% |
| 2008-12-31 | €509.52 Million ≈ $595.68 Million |
+57.05% |
| 2007-12-31 | €324.44 Million ≈ $379.30 Million |
+21.57% |
| 2006-12-31 | €266.87 Million ≈ $312.00 Million |
+31.62% |
| 2005-12-31 | €202.75 Million ≈ $237.04 Million |
-41.27% |
| 2004-12-31 | €345.22 Million ≈ $403.60 Million |
-31.03% |
| 2003-12-31 | €500.56 Million ≈ $585.21 Million |
-27.47% |
| 2002-12-31 | €690.15 Million ≈ $806.86 Million |
-9.72% |
| 2001-12-31 | €764.48 Million ≈ $893.75 Million |
+1.52% |
| 2000-12-31 | €753.05 Million ≈ $880.39 Million |
-- |
About Ion Beam Applications SA
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. Thi… Read more